Envarsus 0.75mg; 1mg; 4mg prolonged-release tablet
*Company:
Chiesi LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) Educational materials for HCP (doctor/pharmacist)
Risk Minimisation Materials
(Click to Download) Envarsus Patient Card
Risk Minimisation Materials